Adipocytokine resistin and breast cancer risk

Breast Cancer Research and Treatment

Volumn 123, Issue 3, 2010, Pages 869-876

  Sun, Chien An ^a   Wu, Mei Hsuan ^a   Chu, Chi Hong ^b   Chou, Yu Ching ^c   Hsu, Giu Cheng ^b   Yang, Tsan ^d   Chou, Wan Yun ^a   Yu, Cheng Ping ^b   Yu, Jyh Cherng ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d MEIHO UNIVERSITY   (Taiwan)

Author keywords

Adipocytokine; Breast cancer; Inflammation; Obesity; Resistin

Indexed keywords

ADIPOCYTOKINE; ESTROGEN; RESISTIN; RETN PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ANTHROPOMETRY; BLOOD LEVEL; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GENERAL HOSPITAL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MENARCHE; MENOPAUSE; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; TAIWAN; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ARTICLE; BLOOD; BREAST TUMOR; CHI SQUARE DISTRIBUTION; ESTROGEN THERAPY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREMENOPAUSE; PROGNOSIS; RISK; RISK FACTOR; UPREGULATION;

ADIPOSITY; ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RESISTIN; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 79952118048     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0792-4     Document Type: Review

References (39)

1. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565-574 (Pubitemid 34993644)
2. Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13:279-292 (Pubitemid 43886659)
3. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-282
4. Rose DP, Komninou D, Stephenson GD (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5:153-165 (Pubitemid 38998240)
5. Housa D, Housova J, Vernerova Z, Haluzik M (2006) Adipocytokines and cancer. Physiol Res 55:233-244
6. Garofalo C, Surmacz E (2006) Leptin and cancer. J Cellular Physiol 207:12-22
7. Hu X, Juneza SC, Maihle NJ, Cleary MP (2002) Leptin: A growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94:1704-1711 (Pubitemid 35446839)
8. Liu CL, Chang YC, Cheng SP, Chern SR, Yang TL, Lee JJ, Guo IC, Chen CP (2007) The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 72:75-81
9. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC, Sun CA (2009) Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer 100:578-582
10. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: A systematic review. Br J Cancer 94:1221-1225
11. Miyoshi Y, Funaha shi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S (2003) Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9:5699-5704 (Pubitemid 37499493)
12. Tworoger SS, Heather Eliassen A, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocr Metab 92:1510-1516 (Pubitemid 46556432)
13. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA (2007) Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 14:669-677 (Pubitemid 350074056)
14. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr., Shelton DL, Hebert CC (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055 (Pubitemid 30608543)
15. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312 (Pubitemid 32151228)
16. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, Richart C (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12:962-971
17. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Hulbrook JD, Plumpton C, Macphee CH, Smith SA (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300:472-476 (Pubitemid 38375833)
18. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR (2003) Resistin messenger RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309:286-290 (Pubitemid 37025889)
19. Rajala MW, Scherer PE (2003) Minireview: the adipocyte-At the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinol 144:3765-3773 (Pubitemid 37088727)
20. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veres A (2004) Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27:2450-2457 (Pubitemid 39281400)
21. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111:932-939 (Pubitemid 40279897)
22. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancerrelated inflammation. Nature 454:436-444
23. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 63:6096-6101 (Pubitemid 37187516)
24. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH (2004) Antibiotic use in relation to the risk of breast cancer. JAMA 291:827-835 (Pubitemid 38543770)
25. Helfer LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, Koelbl H, Heinze G, Reinthaller A, Tong-Cacsire D, Tempfer C, Zeillinger R (2005) Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in Caucasian women. Clin Cancer Res 11:5718-5721 (Pubitemid 41170295)
26. Siemes C, Visser LF, Coebergh JWW, Splinter TAW, Witteman JCM, Uitterlinden AG, Hofman A, Pols HAP, Stricker BHC (2006) C-reactive protein levels, variation in the c-reactive protein gene, and cancer risk: the Rotterdom Study. J Clin Oncol 24:5216-5222 (Pubitemid 46631365)
27. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC, Sun CA (2010) Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study. Int J Cancer 126:508-514
28. Hosmer DW, Lemeshow S (2002) Applied logistic regression, 2nd edn. Wiley, New York, USA
29. Pan WH, Lee MS, Chuang SY, Lin YC, Fu ML (2008) Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan. Obes Rev 9(Suppl 1):22-31
30. Maeso Fortuny MC, Brito Diaz B, Cabrera de León A (2006) Leptin, estrogens and cancer. Mini Rev Med Chem 6:897-907 (Pubitemid 44194377)
31. Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, Sun Y, Wu Q, Chen L (2007) Adipocytokines and breast cancer risk. Chin Med J 120:1592-1596 (Pubitemid 47595751)
32. Kang JH, Yu BY, Youn DS (2007) Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 22:117-121
33. McTernan CL, McTernan PG, Harten AL, Levick PL, Barnett AH, Kumar S (2002) Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47 (Pubitemid 34119198)
34. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789-5795 (Pubitemid 40593223)
35. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919
36. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM (2002) Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 10:1-5 (Pubitemid 135686624)
37. Vidal-Puig A, O'Rahilly S (2001) Resistin: A new link between obesity and insulin resistance? Clin Endocrinol 55:437-438 (Pubitemid 32955479)
38. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 100:3913-3918 (Pubitemid 36418131)
39. Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27 (Pubitemid 28376821)